Page last updated: 2024-11-02

pentoxifylline and Osteosarcoma

pentoxifylline has been researched along with Osteosarcoma in 1 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" In this study we discussed the combined effects of CDDP and caffeine or pentoxifylline using human osteosarcoma cells (OST strain)."3.67[DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors]. ( Sasaki, T; Tomita, K; Tsuchiya, H, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomita, K1
Tsuchiya, H1
Sasaki, T1

Other Studies

1 other study available for pentoxifylline and Osteosarcoma

ArticleYear
[DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:3 Pt 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Cell Division;

1989